Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2006;113:2374-2376
doi: 10.1161/CIRCULATIONAHA.106.626036
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, P. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, P. J.
Related Collections
Right arrow Arrhythmias, clinical electrophysiology, drugs

(Circulation. 2006;113:2374-2376.)
© 2006 American Heart Association, Inc.


Editorial

Rate Control

Is Local Better?

Paul J. Wang, MD

From Stanford University School of Medicine, Stanford, Calif.

Correspondence to Paul J. Wang, MD, Stanford University School of Medicine, 300 Pasteur Dr, Stanford, CA 94305-5233. E-mail pwang@cvmed.stanford.edu


Key Words: Editorials • antiarrhythmia agents • atrioventricular node • catheters • fibrillation


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

The control of ventricular rate plays an important role in the management of patients with atrial fibrillation, decreasing symptoms and improving cardiac function, exercise capacity, and quality of life.1–3 Oral or intravenous agents are routinely administered to achieve adequate control of the ventricular rate by modulating atrioventricular nodal function. The systemic effects of calcium channel antagonists and ß-adrenergic receptor antagonists on blood pressure and other adverse effects, however, may limit use of these agents in some patients. In other patients, it may be difficult to achieve adequate rate control with the use of pharmacological agents.

Article p 2383

In their article in this issue of Circulation, Sigg et al4 describe the novel approach of delivering pharmacological agents via a luminal catheter secured to the region of the atrioventricular node. Using a steerable electrophysiological catheter, they locate the His bundle potential and the coronary sinus ostium and display these positions in 2 orthogonal planes. The luminal catheter is screwed into the myocardium, and third-degree atrioventricular block resulting from the injection of a 1-mg dose of acetylcholine is used to confirm the proper positioning of the luminal catheter. The authors demonstrate that varying degrees of atrioventricular nodal blockade may be achieved by continuous infusion of acetylcholine at rates between 10 and 200 µg/min. In comparison, the intravenous injection of 1 mg acetylcholine did not cause atrioventricular block in any animal, demonstrating that a significant part of the effect of the direct luminal infusion was local. The authors provide histological evidence that . . . [Full Text of this Article]